Lotus Tech Responds to Canada's New Tariff Policy, Positive for Eletre Model in the CountryNEW YORK, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider has expressed significant attention and a warm welcome to the new tariff policy announced by the Canadian government. Prime Minister Mark Carney announced that Canada will allow an initial annual cap of 49,000 Chinese electric vehicles (“EV”) into the Canadian market under a preferential tariff rate of 6.1%. This landmark policy adjustment not only signifies positive progress in China-Canada trade relations but also strongly propels the further development of Lotus Tech in the North American market.
STUBHUB URGENT CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds StubHub Investors of the January 23rd Class Action Lawsuit DeadlineBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In StubHub (STUB) To Contact Him Directly To Discuss Their Options
4DMT Announces New Employment Inducement GrantsEMERYVILLE, Calif., Jan. 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on January 13, 2026, the compensation committee of the Company’s board of directors granted four new non-executive employees 23,600 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.
CGTN: How China, Canada promote steady, solid and sound development of bilateral ties under new circumstancesCGTN published an article on Chinese President Xi Jinping's meeting with Canadian Prime Minister Mark Carney. Centered on the development of bilateral relations, the article highlighted that the two countries share broad prospects for cooperation, and explored how China and Canada are committed to promoting the steady, solid and sound development of bilateral ties under the new circumstances.
VENU Investigation: Investors Encouraged to Contact Kirby McInerney LLPNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Venu Holding Corporation (“Venu” or the “Company”) (
NYSE:VENU) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud InvestigationNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (
NASDAQ: SLNO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
CN Statement on STB Rejection of Incomplete UP–NS Merger ApplicationHOMEWOOD, Ill., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (
NYSE: CNI) today issued the following statement in response to the Surface Transportation Board’s decision rejecting the UP–NS merger application as incomplete:
BBWI Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Bath & Body Works, Inc. Class Action LawsuitSAN DIEGO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Bath & Body Works, Inc. (
NYSE: BBWI) securities between June 4, 2024 and November 19, 2025. Bath & Body Works is a specialty retailer of home fragrance and body care products.
CRWV Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the CoreWeave, Inc. Class Action LawsuitSAN DIEGO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired CoreWeave, Inc. (
NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025. CoreWeave purports to be an artificial intelligence (“AI”) cloud computing company and self-described “Hyperscaler”, which it defines as “a cloud provider or technology company that is capable of delivering computing infrastructure and services at massive scale, typically through large data centers and geographically distributed networks."
GBank Financial Holdings Inc. Announces Fourth Quarter 2025 Quarterly Earnings Call Scheduled for Wednesday, January 28th, at 2:00 P.M., Pacific TimeLAS VEGAS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- GBank Financial Holdings Inc. (the "Company") (Nasdaq: GBFH), the parent company for GBank (the "Bank"), today announced it plans to release its fourth quarter 2025 financial results on Wednesday, January 28, 2026 at approximately 1:15 p.m. PST, and will host its quarterly earnings call on Wednesday, January 28, 2026, at 2:00 p.m. PST. Interested parties can participate remotely via Internet connectivity. There will be no physical location for attendance.
VERSES® Restructures to Focus on Core Target MarketVANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, today announces a refocused corporate strategy designed to concentrate resources on the Company’s core target markets and highest-priority initiatives.
CRWV: Kirby McInerney LLP Advises Coreweave, Inc. Investors of Class Action LawsuitNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Coreweave, Inc. (“Coreweave” or the “Company”) (
NASDAQ:CRWV) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
LAKE Investigation: Investors Encouraged to Contact Kirby McInerney LLPNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Lakeland Industries, Inc. (“Lakeland” or the “Company”) (
NASDAQ:LAKE) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
SLM INVESTOR ALERT: Kirby McInerney LLP Advises SLM Corporation a/k/a Sallie Mae Investors of Class Action LawsuitNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased SLM Corporation a/k/a Sallie Mae (“SLM” or the “Company”) (
NASDAQ: SLM) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Western Uranium & Vanadium Announces Securities TransactionsToronto, Ontario and Nucla, Colorado, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” or the “Company”) is pleased to provide the following updates.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SAN CARLOS, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (
NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on January 15, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 97,710 shares of Iovance’s common stock to 17 new, non-executive employees.
Christina Lake Cannabis Announces Sale of Bare LandVANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that it has completed a sale of its 99 acres of non-core land at 46 Ponderosa Drive in Christina Lake, British Columbia (the "Land"). Pursuant to the sale of the Land, the Company sold the bare un-serviced Land to an arm's length third party for aggregate gross proceeds of $551,000 (the "Sale Transaction"). The Land is not required for the Company's current or anticipated operations and was classified as a non-core asset following the Midway acquisition in February 2024, which provides sufficient land to support the Company's long term objectives. The disposition of the Land strengthens the Company’s balance sheet and enhances liquidity while allowing management to remain focused on its core operating assets. Proceeds from the Sale Transaction will be used for general working capital for the Company.
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) INVESTOR ALERT Investors With Large Losses in Vistagen Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (
NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, inclusive.
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on January 9, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).
J & J SNACK FOODS SCHEDULES FISCAL 2026 FIRST QUARTER EARNINGS CONFERENCE CALL AND WEBCASTMOUNT LAUREL, N.J., Jan. 16, 2026 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) today announced that it will release financial results for its fiscal first quarter ended December 27, 2025, before the stock market opens on Tuesday, February 3, 2026. The Company will hold a conference call and webcast to discuss the results at 10:00 a.m. Eastern Time that same day.
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price DeficiencyHONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the “Notification Letter”) dated January 12, 2026 from Nasdaq's Listing Qualifications Department indicating that the closing bid price of the Company's class A ordinary shares of par value of US$0.001 each was below the minimum requirement of US$1.00 per share for 30 consecutive business days from November 26, 2025 through January 9, 2026, and the Company was therefore currently not in compliance with the minimum bid price requirement set forth under Nasdaq listing rule 5550(a)(2).
NusaTrip Incorporated Announces Waiver of Society Pass Lock-Up AgreementJakarta, Jan. 16, 2026 (GLOBE NEWSWIRE) -- NusaTrip Incorporated (Nasdaq: NUTR) (“NusaTrip,” “NUTR,” or the “Company”), a travel ecosystem with geographical specialization in Southeast Asia and Asia-Pacific, today announced that its initial public offering underwriter, Cathay Securities, Inc., has given its consent to grant an early release to Society Pass Incorporated (Nasdaq: SOPA) from its securities lock-up agreement associated with NusaTrip’s initial public offering.
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced that on January 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase 100,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
Turbo Energy Receives Nasdaq Notice Regarding Minimum Stockholders’ Equity RequirementVALENCIA, Spain, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Turbo Energy S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global provider of AI-optimized solar energy storage technologies and solutions, today announced that it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on January 12, 2026, notifying the Company that it is no longer in compliance with Nasdaq Capital Market continued listing requirements.
Coherent Introduces Germanium-Free Electro-Optic Modulator for High-Speed CO2 Laser Via DrillingSAXONBURG, Pa., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (
NYSE: COHR), a global leader in photonics, today announced the release of a new electro-optic modulator (EOM) designed for high-speed switching of CO₂ lasers in via drilling applications for the semiconductor industry. The new EOM provides a germanium-free solution capable of sub-microsecond pulse generation at laser powers up to 300W, addressing both performance demands and supply-chain constraints.
Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical CathetersSAXONBURG, Pa., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (
NYSE: COHR), a global leader in photonics, today announced the launch of AxioView™ imaging fiber assemblies, designed for optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and multimodal catheter-based imaging systems. AxioView™ will debut this month at Photonics West.
Avista files four-year rate plan in Washington to support reliable service and maintain critical infrastructureProposal aims to deliver predictable costs while addressing grid upgrades, wildfire resiliency, and higher power supply expenses.
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on January 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase 8,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)VANCOUVER, British Columbia and BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to ten new non-officer employees consisting of an aggregate of 42,300 share options. All of the foregoing share options were approved by the Compensation Committee of the Company’s Board of Directors with an effective date of January 15, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted non-qualified stock option awards to purchase an aggregate of 120,000 shares of its common stock to two new employees as an inducement material for accepting employment with Context.
Hain Celestial Announces Fiscal 2026 Second Quarter Earnings Results Conference Call and WebcastHOBOKEN, N.J., Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, will release its fiscal second quarter financial results before the market opens on Monday, February 9, 2026. The company will host a conference call, which will be webcast, to discuss the results at 8:00 AM ET.
Inter Gains Federal Reserve Approval to Establish U.S. Banking BranchMIAMI, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Inter (
NASDAQ: INTR), the financial institution serving more than 41 million customers, has received regulatory approval from the Florida Office of Financial Regulation (OFR) and the Federal Reserve (FED) to establish a state‑licensed international banking branch in Florida, marking a significant milestone in its international expansion.
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.325 PER COMMON SHARE AND APPOINTS NEW BOARD MEMBERNEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (
NASDAQ: VALU) announced today that its Board of Directors declared on January 16, 2026 a quarterly cash dividend of $0.325 per common share, payable on February 10, 2026, to stockholders of record on January 26, 2026. The Company has 9,387,957 shares of common stock outstanding as of January 16, 2026. The Company also announced that the Board has appointed Dr. Alexander J. Swistel to its Board of Directors and as a member of the Board’s Audit Committee.
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary SharesBOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the closing of its previously announced Company best efforts registered direct offering ("Offering") of 7,040,000 ordinary shares at an offering price of $1.25 per ordinary share conducted without an underwriter or placement agent to members of senior management and existing shareholders. The gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, were $8.8 million. For every ordinary share subscribed, participants will receive one warrant entitling the holder to subscribe for one new ordinary share at a price of $1.50 at any time up to and including July 16, 2026 (when the warrants expire) resulting in additional gross proceeds of up to approximately $10.56 million.
A Shocking Exposé of the Rich and Powerful’s Web of Deceit In A Small TownPalmetto Publishing Announces the Release of WHEN MONEY AND POWER DO NOT BUY CLASS OR INTEGRITY
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen TherapeuticsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis StudyMELBOURNE, Australia, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study), a Phase 3 trial to evaluate the use of Telix’s commercial PSMA-PET1 imaging agents, Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) and Gozellix® (kit for the preparation of gallium Ga 68 gozetotide injection) in the initial prostate cancer diagnosis setting. The dose was administered under the supervision of Dr. Brian Mazzarella at Urology Austin and supplied by RLS Radiopharmacies.
Denny’s Corporation Announces Completion of Acquisition by TriArtisan Capital Advisors, Treville Capital Group and Yadav EnterprisesSPARTANBURG, S.C., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Denny’s Corporation (the “Company” or “Denny’s”) (
NASDAQ: DENN), owner and operator of Denny’s Inc. and Keke’s Inc., today announced the successful completion of its previously announced acquisition by TriArtisan Capital Advisors LLC (“TriArtisan”), Treville Capital Group (“Treville”) and Yadav Enterprises, Inc. (“Yadav Enterprises”). The transaction closed following approval by Denny’s stockholders as well as satisfaction of all required regulatory and customary closing conditions.
Indra Group Is to Manage the Ticketing and Access Control Systems Across London's Public Transportation Network for Close to 1,000 Million EurosMADRID, Spain, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Indra Group has won one of the largest contracts in its history. Transport for London (TfL) has awarded the company the project to operate the ticketing and access control system of the entire public transportation network of London and its metropolitan area, the most advanced, innovative and trailblazing system in the western world, as well as its maintenance and development until 2034, for an amount of 524 million pounds sterling (605 million euros), extendable to over 845 million pounds sterling (975 million euros). The signed contract includes possible extensions and options until 2039.
DC Utility Regulator Opens Investigation into Energy AffordabilityWashington, DC, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Public Service Commission of the District of Columbia (Commission) has opened an investigation into ways to mitigate rising energy costs affecting District residents and businesses (Formal Case No. 1186, Order No. 22774). Prompted by a petition from the Office of the People's Counsel, this proceeding aims to assess and enhance energy affordability measures to protect ratepayers. The Commission seeks public and stakeholder comments to define the scope, topics, and prospective timeline for the investigative process. Initial comments are due by February 16, 2026, and reply comments are due by March 2, 2026.
Demand for chicken keeps climbing. Can broiler production keep pace?Larger birds and value-added product offerings drive growth while challenges limit processing plant expansion
December Retail Sales Reinforce the 2025 Spending Plateau, Reports CircanaConsumers continue to spend, but reduced demand conveyed clear thresholds even through the holiday shopping season.
UPDATE - Rackspace Technology Secures VMware Sovereign Cloud Partner StatusPartner Status empowers UK organisations to harness advanced digital capabilities without compromising sovereignty, security or sustainability
Five Star Bancorp Declares Fourth Quarter Cash DividendRANCHO CORDOVA, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.25 per share on the Company’s voting common stock. The dividend is expected to be paid on February 9, 2026, to shareholders of record as of February 2, 2026. This dividend represents an increase of $0.05 per share, the first increase of the dividend since April 2023. This increase is emblematic of the continued strength of the Company’s financial performance, the execution of a successful organic growth strategy, and a steadfast commitment to serving clients, community partners, and employees.
Transaction in Own SharesTransaction in Own Shares
Daiso USA Launches Official Mascot, “DAIZO”Anaheim, CA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Daiso USA is pleased to announce the US launch of Daiso's new official character, “DAIZO,” on Friday, January 16, 2026.
$1.1 Billion Aerospace Complex, Nation’s Most Advanced Aerospace Testing Facility, Anchors Minnesota’s Strategy to Build the Next EconomyROSEMOUNT, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- St. Paul-based North Wind is investing $1.1 billion to build a new, state-of-the-art aerospace and hypersonic research and testing complex in Rosemount—the nation’s most advanced aerospace research and development testing facility. The project is a major public-private partnership and investment in Minnesota’s innovation economy while significantly expanding the nation’s limited capacity for advanced high-speed aerospace testing.
